Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
Nasim Mavaddat(MRC Epidemiology Unit), Kristiina Aittomäki(University of Helsinki), Minouk J. Schoemaker(Institute of Cancer Research), Nichola Johnson(Institute of Cancer Research), Marjanka K. Schmidt(University of Cambridge), Jonathan P. Tyrer(University of Cambridge), Emiel J. Rutgers(Oncode Institute), Fergus J. Couch(Mayo Clinic), Grethe Grenaker Alnæs(University of Copenhagen), Jonine D. Figueroa, Frank Dudbridge(University of Cambridge), Annegien Broeks, Anthony J. Swerdlow(Institute of Cancer Research), Joe Dennis(University of Cambridge), Mikael Eriksson(Herlev Hospital), Alison M. Dunning(University of Cambridge), Kamila Czene(Karolinska Institutet), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Mark N. Brook(Institute of Cancer Research), Hans Wildiers(KU Leuven), Silje Nord(Oslo University Hospital), Robert Luben(University of Cambridge), Heli Nevanlinna(University of Helsinki), Celine M. Vachon(Leiden University Medical Center), Louise A. Brinton(National Cancer Institute), Nick Orr(United States Department of Health and Human Services), Mitul Shah(University of Cambridge), Stig E. Bojesen(University of Copenhagen), Chantal Van Ongeval(KU Leuven), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Børge G. Nordestgaard(Gentofte Hospital), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Janet E. Olson(Cornell University), V. Shane Pankratz(University of New Mexico), Stephen J. Chanock(National Cancer Institute), Taru Muranen(Karolinska Institutet), Qin Wang(University of Cambridge), Judith Brown(Cancer Research UK), Alan Ashworth(University of California, San Francisco), Hatef Darabi, Anne‐Lise Børresen‐Dale(Oslo University Hospital), Vessela Kristensen(Roche (Switzerland)), Erik Van Limbergen, Senno Verhoef(The Netherlands Cancer Institute), Sune F. Nielsen(Herlev Hospital), Julian Peto(University of Helsinki), Henrik Flyger(Herlev Hospital), Jolanta Lissowska, Manjeet K. Bolla(University of Cambridge), Isabel dos‐Santos‐Silva(London School of Hygiene & Tropical Medicine)
Cited by 570
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k